Information Provided By:
Fly News Breaks for September 15, 2016
ALXN
Sep 15, 2016 | 07:30 EDT
FBR Capital analyst Christopher James started Alexion Pharmaceuticals with an Underperform rating and $82 price target.
News For ALXN From the Last 2 Days
There are no results for your query ALXN